We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Three weeks ago, studies exposed a new type of 'coronavirus' as the most likely culprit behind SARS, or severe acute respiratory syndrome.

Until then, coronaviruses were something of a backwater in the field of virology. But the ongoing epidemic of SARS is shining an intense spotlight on this group of respiratory viruses, with hordes of government, academic and corporate scientists now rushing to characterise the virus further and test possible drugs and vaccines.

In this feature article, Martin Enserink gets to grips with the science behind the SARS virus — the genome of which was deciphered last weekend — and its implications for developing a vaccine against this deadly pathogen.

Link to Science article

Reference: Science 300, 413 (2003)

Related topics